Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Roche's trontinemab data showed dose-dependent amyloid reduction in Alzheimer's patients, while its Elecsys pTau181 test aims ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Dismissal of long-standing Alzheimer's research ignores the voices of those who matter most: patients, caregivers and doctors.

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells ...

researchers studying the autopsied brains of people with Alzheimer’s discovered that they were clogged with sticky plaques made from beta amyloid proteins and toxic tangles made of a protein ...

Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s ...

A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who are yet to show symptoms. The just-published results from a clinical trial ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...